University of California
San Francisco, California, United States
NCT Number: NCT00051792
The purpose of this study is to evaluate the safety and effectiveness of yoga in reducing shortness of breath in people with chronic obstructive pulmonary disease (COPD). Patients in this study must have moderate to severe COPD and be primarily limited by shortness of breath.
Looking for future studies?
Notify Me40 year and older
All sexes
Interventional
Phase 1 / Phase 2
San Francisco, California, United States
Management of dyspnea (shortness of breath) is a major concern for patients with COPD. The efficacy of complementary exercises to manage dyspnea is unknown. Complementary exercises may be more congruent with patients' lifestyles and values than traditional exercise programs and can be adapted to changes in illness severity and disability. Yoga practice is a complementary therapy that people use to manage their dyspnea. The aims of this study are to: 1) develop a safe and feasible yoga program for patients with COPD; 2) test the efficacy of this program; and 3) determine whether physical performance, psychological well being, and health-related quality of life are positively affected by yoga practice.
Patients in this study will be randomized to receive yoga training or usual care for 12 weeks. Patients will be evaluated at study entry, after each session, and immediately after the training program.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
National Center for Complementary and Integrative Health (NCCIH)
Nih
Efficacy of Yoga for Self-Management of Dyspnea in COPD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01515709
Bronchial Diseases, Bronchitis
Harefield, United Kingdom
View Trial DetailsNCT01507415
Bronchial Diseases, Bronchitis
Uxbridge, United Kingdom
View Trial DetailsNCT00683722
Bronchial Diseases, Bronchitis
Los Angeles, California, United States
View Trial DetailsNCT00680056
Bronchial Diseases, Bronchitis
São Paulo, Brazil
View Trial Details